BREAKING NEWS

WHO declines comment on remdesivir in COVID-19, hopes for best

By REUTERS

APRIL 29, 2020 20:12

GENEVA - A top World Health Organization official declined comment on Wednesday on reports that Gilead Science's remdesivir could help treat COVID-19, the respiratory disease caused by the novel coronavirus, but said that further data was needed.

"I wouldn't like to make any specific comment on that, because I haven't read those publications in detail," Dr Mike Ryan, head of the WHO's emergencies program, told an online briefing in response to a question, adding it can sometimes take a number of publications to determine a drug's efficacy.

"Clearly we have the randomized control trials that are underway both in the UK and US, the 'Solidarity trials' with WHO. Remdesivir is one of the drugs under observation in many of those trials. So I think a lot more data will come out," he said.

Ryan added: "But we are hopeful this drug and others may prove to be helpful in treating COVID-19."

Ukraine's drone attack sparks industrial fire in Russia's Kaluga

By REUTERS

11/25/2024 01:29 AM

White House condemns murder of Chabad emissary Zvi Kogan

By JERUSALEM POST STAFF

11/25/2024 01:26 AM

IDF announces military exercise to take place in Eilat area on Monday

By JERUSALEM POST STAFF

11/24/2024 10:41 PM

Iran Embassy in UAE rejects Iran's involvement in Rabbi's murder

By JERUSALEM POST STAFF